aTyr Pharma | LIFE - Należności Handlowe





Należności Handlowe Zmiana Data
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Ardelyx USD 82.84M 10.99M 2026-03
aTyr Pharma USD 906K 295.84M 2026-03
Biogen USD 1.79B 76.6M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Cipla INR 62.19B 12.42B 2026-03
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.34M 44K 2026-03
CSL USD 4.32B 1.35B 2025-12
Curis USD 2.55M 400K 2024-06
GlaxoSmithKline GBP 7.94B 178M 2026-03
Grifols EUR 1B 285.88M 2025-12
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Roche Holding CHF 11.9B 460M 2025-12
United Therapeutics USD 312M 38.2M 2026-03
Xoma USD 14.78M 4.96M 2024-06